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Abstract
Global gene expression analysis of human embryonic stem cells (hESCs) that differentiate into neural cells would help to
further define the molecular mechanisms involved in neurogenesis in humans. We performed a comprehensive
transcripteome analysis of hESC differentiation at three different stages: early neural differentiation, neural ectoderm, and
differentiated neurons. We identified and validated time-dependent gene expression patterns and showed that the gene
expression patterns reflect early ESC differentiation. Sets of genes are induced in primary ectodermal lineages and then in
differentiated neurons, constituting consecutive waves of known and novel genes. Pathway analysis revealed dynamic
expression patterns of members of several signaling pathways, including NOTCH, mTOR and Toll like receptors (TLR), during
neural differentiation. An interaction network analysis revealed that the TGFb family of genes, including LEFTY1, ID1 and
ID2, are possible key players in the proliferation and maintenance of neural ectoderm. Collectively, these results enhance
our understanding of the molecular dynamics underlying neural commitment and differentiation.
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Introduction
Embryonic stem cells (ESCs) are a promising tool for the study
of neural development and cell lineage specification. The current
lack of knowledge about cues for mammalian neuronal commit-
ment and differentiation is at least partly due to a paucity of
available model systems that permit direct observation of
developmental processes. Studies of the molecular mechanisms
underlying the neural differentiation of human ESCs (hESCs) can
help to unravel the complex gene pathways that are involved in
neural cell commitment and differentiation processes. High
throughput studies of gene expression have been applied to neural
stem cells (NSCs) derived from the subventricular zone (SVZ) [1],
NSCs derived from mouse ESCs and the fetal brain [2],
dopaminergic neurons from mouse ESCs [3], heterogeneous
neural cells from mouse ESCs [4] and neural progenitors (NPs)
differentiated from mouse ESCs [5] and forebrain periventricular
zone NPs compared to neuroectoderm from mESCs [6].
Cytoskeletal genes, cell membrane receptor genes, and transcrip-
tion factor genes are differentially expressed in most cell types.
Recently, Wu et al. (2010) analyzed the transcriptome of hESCs
during differentiation into the neural lineage at the early initiation,
neural progenitor, and early glial-like stages [7] and found an
extraordinary degree of stage-specific transcription and splicing.
The diversity was highest in undifferentiated hESCs and decreased
upon differentiation [7].
Previously, we described the differentiation of hESCs into NPs
and neural cells with typical cellular, molecular and ultrastructural
markers using a defined adherent culture protocol [8,9]. Here we
analyzed the transcriptome of hESCs during differentiation into
neural cells [8] using a whole genome microarray chip. We
identified differentially expressed genes that may be linked to
neural fate specification, proliferation, and differentiation. Our
data extend the gene expression network for neural differentiation
and reveal novel aspects of transcriptional control pathways
underlying the multistep process of commitment and differentia-
tion of hESCs into neural cells.
Materials and Methods
Human ESC culture and sample preparation
The hESC line Royan H6 [10] was passaged and cultured
under feeder-free culture conditions on Matrigel in hESC medium
containing DMEM/F12 medium supplemented with 20% knock-
out serum replacement, 2 mM L-glutamine, 1% nonessential
amino acids, 100 units/ml penicillin and 100 mg/ml streptomycin,
insulin-transferrin-selenite, (All from Invitrogen), 0.1 mM b-
mercaptoethanol and 100 ng/ml basic-fibroblast growth factor
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22856(bFGF, Royan Institute). The cells were grown in 5% CO2 and
95% humidity, and they were further passaged every 7 days. For
passaging, hESCs were treated with collagenase IV (0.5 mg/ml,
Invitrogen): Dispase (1 mg/ml, Invitrogen) at 37uC for 5–7 min
then the enzyme was removed and washed with PBS. Cells were
collected by gently pipetting and replated on matrigel coated
dishes and the medium changed every other day [8].
Neural differentiation
Neural differentiation was induced as described previously [8].
Briefly, seven-day hESCs were induced to neural phenotype by
20 ng/ml bFGF, retinoic acid (RA, 2 mM, Sigma-Aldrich), Noggin
(500ng/ml, R&D), Shh (50 ng/ml, R&D), and leukemia inhibitory
factor (LIF, 10 ng/ml, chemicon) for two days (NI stage). Cells
were incubated for an additional seven days without Noggin and
SHH until neuroectodermal islands with columnar cells, known as
rosette structures, appeared (NE stage). For a further week RA
removed from the medium and during this time, the rosette
structures changed into neural tube-like structures (NT stage).
These structures were separated manually from the surrounding
flat cells with a sterile pulled-glass pipette under the phase contrast
microscope (10X, Olympus, CKX41). The neural tube-like
structures were dissociated into single cell by 0.01% trypsin
(Invitrogen)/2 mM disodium EDTA and then replated on laminin
(5 mg/ml, Sigma-Aldrich) and poly L-Ornithine (15 mg/ml,
Sigma-Aldrich)-coated tissue culture dishes to generate differenti-
ated neural cells (DN stage) in neurobasal medium, supplemented
with 2% N2 and 2% B27, 2.5% fetal bovine serum (All from
Invitrogen), ascorbic acid (AA, Sigma-Aldrich), fibronectin (5 mg/
ml, Sigma-Aldrich), laminin (1 mg/ml, Sigma-Aldrich), BDNF
(20 ng/ml, R&D), GDNF(20 ng/ml, Sigma-Aldrich) and db-
cAMP(1 ng/ml, Sigma-Aldrich) for up to 14 days.
Immunofluorescence staining and flow cytometry
analysis
To perform immunofluorescence staining, cells were fixed in
4% paraformaldehyde for 20 minutes, permeabilized with 0.2%
Triton X-100 for 10 minutes and blocked in PBS with 10% serum
of host which secondary antibody was derived in PBS for 1 hour.
Cells were incubated with primary antibody for 1 hour at 37uC,
washed, and incubated with fluorescein isothiocyanate (FITC)-
conjugated secondary antibodies for 1 hour at 37uC. The primary
antibodies used were Oct4 (1:100, Santa Cruz Biotechnology, SC-
5279) and Nanog (1:100, Santa Cruz Biotechnology, SC-30331)
for undifferentiated hESC determination and anti-Nestin, Sox1,
Pax6, microtubule-associated protein monoclonal IgG (MAP2),
glial fibrillary acidic protein (GFAP), serotonin, and tyrosine
hydroxylase (TH) for differentiated cell determination. The
complete information for and concentrations of the antibodies
have been described previously [8]. The nuclei were counter-
stained with DAPI or propidium iodide (PI). Cells were analyzed
with a fluorescence microscope (Olympus, Japan). Flow cytometry
analysis for Nestin, Sox1, and Pax6 was performed as described
previously [8].
Electrophysiology analysis
Whole cell patch clamp recording method was used for
functional testing of differentiated cells in 30 days post induction
which cultured on cover slip. The record was carried out in the
room temperature (25uC) and cell currents were recorded in
voltage clamp mode. Patch electrode (Filament borosilicate glass,
1.5 mm outer diameter, HARVARD apparatus, GC150F-10)
resistance brought up to 3 to 5 M. and pulled used horizontal
puller (Sutter Instruments P-97 USA). Recorded signal amplified
and filtered (2 KHz low-pass Bessel Filter) using Multiclamp 700B
amplifier (Axon instrument, USA). Amplified signals were
acquired at 10 KHz using a Digidata 1440 analog-to-digital (A/
D) board and PClamp 10 software (Axon instrument, USA).
All voltage protocol will describe in result section. The signals
analyzed by Clampfit10 software (Axon instrument, USA) in off-
line mode. For recording cell currents the bath solution was used
(mM): Nacl 160, CaCl2 2, HEPES 10, D-Glucose 10. The solution
pH adjusted in 7.4 by using NaOH and osmolarity kept around
300 mOsm The pipette solution contained: CsCl2 (130 mM),
MgCl2 (2 mM), TEA-Cl (20 mM), EGTA (10 mM), HEPES
(10 mM), and D-Glucose (10 mM) adjusted to PH 7.2 by using
KOH and osmolarity kept around 300 mOsm. Nifedipin (5 mM)
had been used to block L type Ca
++ channels that indicated and
administrated via super fusion using a fast-exchange perfusion
system (ALA instruments).
Illumina bead chip hybridizations and analysis of
expression data
Differentiated cells that were representative of NI (day 2), NE
(day 9) and DN (day 30) and control hESCs were generated in
triplicate. Total RNA was isolated using Trizol reagent (Invitro-
gen). Approximately 400 ng of total RNA from three biological
replicates per time point served as the input to generate biotin-
labeled cRNA using a linear amplification kit (Ambion, Austin,
TX, United States). RNA and biotinylated cRNA concentrations
were confirmed with Nanodrop ND-1000 and controlled for
quality using a BioRad Experion electrophoresis station. Next,
cRNA samples (750 ng) were hybridized onto Illumina SentrixH
HumanHT-12 v3 Expression Bead Chips at 58 uC overnight
(19 h). Chips were scanned with the Illumina Bead Array Reader
(Factor=1, PMT=520, Filter=100%), and the numerical results
were extracted with GenomeStudio using the Gene Expression
Module v.1.0.6. Raw data were background-subtracted and
normalized using the quantile normalization method (lumi
software package) [11]. Normalized data were filtered for genes
with significant expression levels compared to negative control
beads. Selection for differentially expressed genes was performed
on the basis of arbitrary thresholds for fold changes plus statistical
significance according to the Illumina t-test error model (limma
software) [12]. The mRNA array data in MIAME compliant and
has been submitted to the NCBI Gene Expression Omnibus
(GEO) database (Accession: GSE28633).
Data analysis
All significantly expressed transcripts (P,0.05, FC$1.5) were
clustered using a hierarchical clustering method. The determina-
tion of the correct number of clusters was based on measuring the
similarity of each gene to its own cluster compared to the similarity
of the gene to genes in other clusters, which was measured using
the average of the intracluster and intercluster distances.
MATLAB software (v. 7.3) was used for clustering and correlation.
Expander software (v. 5.07) [13] was used for the hierarchical
clustering of transcripts overexpressed in each stage separately and
cell cycle associated transcripts. Briefly, the fold changes of the
expression values compared to the ESC stage were imported into
the software and standardized with a mean of 0 and a variance of
1. Then, using the average linkage method, transcripts were
clustered, and the expression matrix was visualized with a
dendrogram.
The STRING database (version 8.1) [14] was used to construct
a regulatory network of differentially expressed transcripts. Then,
a regulatory sub-graph was extracted from this network by
Gene Expression Analysis of hESC Differentiation
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tions. The visualization of networks was performed using
Cytoscape (version 2.6.3) [15].
We used BiNGO (a Cytoscape plugin) [16] to find statistically
over- or underrepresented Gene Onthology (GO) categories in the
biological data as a tool to enrich the analysis of the transcriptome
dataset. Enrichment was determined in reference to all human
Entrez GeneIDs that were annotated in the Biological Process
branch (14,394 genes total). P-values were derived from a
hypergeometric test followed by the Benjamini and Hochberg
false discovery rate [17]. A P-value cutoff of 0.01 was used to
identify significantly enriched categories. Pathway analyses were
assigned with the ClueGO (v. 1.2) plugin to all of the genes using
the KEGG database. A two sided hypergeometric test was used as
statistical test for the probability of each gene falling into a
pathway.
Real-Time PCR
Reverse transcription of the isolated RNA was carried out using
the MMLV reverse transcriptase (USB) and oligo-dT primer
according to the manufacturer’s instructions. Real-time PCR was
carried out on an Applied Biosystems 7900 instrument in 25 ml
reactions containing 12.5 ml of SYBR Green PCR mix (Applied
Biosystems, Foster City, CA, United States) and each primer at
0.375 mM. All primers used for the assays were tested for
specificity and amplification efficiency. The sequences of the
primers used are listed in Table S1. Relative mRNA levels were
calculated using the comparative CT method, as described by the
manufacturer (Applied Biosystems, Foster City, CA, United
States), with GAPDH as an internal control for normalization.
Western blot analysis
For each sample, 25 mg of protein was separated by 12% SDS-
PAGE (120 V for 1 h) using a Mini-PROTEAN 3 electrophoresis
cell (Bio-Rad), and the proteins were transferred to a PVDF
membrane (Amersham) using a semi-dry blotting method (Bio-
Rad) and Dunn carbonate transfer buffer (10 mM NaCHO3,
3m MN a 2CO3, 20% methanol). Membranes were blocked for
1.5 h using Western Blocker solution (Sigma, W0138) and then
incubated overnight at 4uC with the respective primary monoclo-
nal antibodies, mouse anti-TH (Sigma, 1:10,000), rabbit anti-
OTX2 (Abcam, 1 ug/ml) or mouse anti-Nestin (Chemicon,
1:1,000). Membranes were then incubated with peroxidase-
conjugated secondary antibodies, anti-mouse IgG (1:5,000, Sigma,
A9044) or anti-rabbit IgG (1:10,000, Sigma, A2074), for 2 hr at
room temperature. Finally, the blots were visualized using ECL
detection reagents (Sigma, CPS-1-120). Subsequently, the films
were scanned with a densitometer (GS-800, Bio-Rad). To insure
that a uniform amount of protein was loaded onto the gels, the
membranes were stained for total protein with Fast Green (FCF,
Sigma-Aldrich, F7252).
Results and Discussion
Differentiation of hESCs into neural cells
The morphology of feeder-free adhesive hESCs was compact
cells with a high nucleus:cytoplasm ratio, resulting in cells with
clear borders (Fig. 1A); they had a typical morphology and the key
pluripotency markers OCT4 and NANOG (Fig. 1B, 1C). The
hESCs were differentiated into NEs by Noggin and RA-mediated
induction [8], which led to the appearance of rosettes with
columnar cells (Fig. 1D) and NT formation. The differentiated
cells, 9 days after induction (NE stage), expressed Nestin (Fig. 1E)
(83.764.9%), Sox1 (Fig. 1F) (46.463.3) and Pax6 (Fig. 1G)
(50.669.5%) (flowcytometry data Fig. 1H), which are neuroecto-
dermal markers expressed during neural plate and NT formation
[18]. We isolated hESC-generated NTs with a pipette (Fig. 1I).
After dissociation, the cells were replated onto laminin/poly-L-
ornithine-coated plates. Neural cell maturation was promoted by
bFGF withdrawal and the addition of ascorbic acid, BDNF,
GDNF, and cAMP (Fig. 1J). Within a few days, numerous
processes grew, and neuronal migration began (Fig. 1K). The
differentiated cells expressed neural markers (MAP2, GFAP,
serotonin, and TH) that were detected by immunofluorescence
staining (Fig. 1L-O). Quantification of the markers was performed
as described previously [8]. To determine the functionality of the
hESC-derived neurons we studied their electrophysiological
properties (Fig. 2). In voltage clamp mode we evaluated voltage-
activated ionic currents after plating. Voltage steps (25 ms
duration) from a holding potential of 270 mV to a range of test
potentials between 290 and +100 mV (10 mV increments)
demonstrated inward currents (Fig. 2A). Inward currents that
inactivated rapidly and were sensitive to Nifedipine, an L type
Ca
++ blocker (5 mM, student t test, P,0.001, n=30) (Fig. 2B, 2C)
Current-voltage relationships showed that inward currents
activated near 240 mV and peaked at 210 mV in matured cell
two weeks after platting. (Fig. 2D) (n=30).
The excitability of hESCs-derived neurons was assayed by
whole cell patch clamping in the current clamp mode. Action
potentials like responces were recorded after plating in 60% of
matured cells (Fig. 2E).
cDNA microarray analysis of hESC-derived neural cells
Three independent biological replicates of undifferentiated
hESCs and cells from the NI, NE and DN stages were analyzed
using whole genome microarray technology. As a first level of
quality control, the transcriptional profiles of all replicate samples
were assessed for biological reproducibility (Figure S1). All
triplicate mRNA samples clustered together. Real time PCR was
carried out to confirm the expression levels of genes selected from
four different groups: (i) pluripotency markers, such as OCT4,
SOX2, ALP, and NANOG (ii) genes that were upregulated during
neural induction (e.g., Nestin, SOX1, PAX6), (iii) neural rosette
cells (e.g., FOXA2), and (iv) genes that were upregulated in
differentiated neurons (e.g., HOXA5, HOXB5, HOXA2, and
TH). In 13 of 14 reactions, microarray-derived differential
expression was confirmed at a confidence level of 92%. For one
gene, ACTB, the background mRNA expression at maturation,
detected by microarray, could not be confirmed by real time PCR
(Fig. 3). For confirmation of the Nestin as a neural progenitor
marker and Tyrosine hydroxylase (TH) as a transcript that was
highly expressed in the differentiated neurons, protein expression
level of Nestin and TH were analyzed by western blotting and
results revealed that differences in mRNA levels actually reflect
differences in protein expression in both cases (Figure S2).
Distinct classes of transcripts are differentially expressed
during neural differentiation
An analysis of transcriptome dynamics during differentiation
revealed that 5955 transcripts were modulated during differenti-
ation in at least one stage compared with hESCs (Table S2). As
expected, the numbers of modulated genes increased during the
differentiation of hESCs to MNs. While 505 and 1785 transcripts
showed differential expression patterns in NIs and NEs, respec-
tively, compared with hESCs, 5134 transcripts were modulated in
MNs compared with hESCs (Fig. 4). While most (73%) of the
modulated genes in NIs were up-regulated, only 48% (2,505) of
regulated genes in the MNs were up-regulated. The minimum
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22856Figure 1. Characterization of undifferentiated and differentiated hESCs toward neural phenotype. Schematic representation of neural
differentiation procedure and stages NI, NE, NT and DN in the upper panel. (A) Phase contrast photomicrographs of a colony of hESCs grown under
feeder-free conditions. The cells show a high ratio of nucleus to cytoplasm and a compact morphology with clear borders. Immunofluorescence
analysis of key hESC markers, including OCT4 (B) and NANOG (C) expression, in hESCs. The hESCs were induced to differentiate into neural ectoderm
by RA, SHH, Noggin and LIF, and the differentiating cells, after 9 days of treatment with extrinsic factors, changed their morphology and formed
rosette type structures (D). Immunostaining for the neural markers Nestin (E), SOX1 (F) and Pax6 (G) and flowcytometry results for neural progenitor’s
marker genes (H) revealed the differentiation of hESCs toward neural cells. Further differentiation of rosette cells in the absence of Noggin, Shh, and
RA for an additional week resulted in NT formation. NTs were then dissected manually (I) and, after dissociation, were replated onto laminin/poly-L-
ornithine-coated dishes (J) for an additional two weeks in neurobasal medium supplemented with N2 and BDNF, GDNF, AA and cAMP to form a pool
of matured neural cells (K). Immunostaining was performed and indicated the presence of differentiated neurons (L), astrocytes (M), serotonergic
neurons (N) and dopaminergic neurons (O). Nucleuses are stained with DAPI and PI (propidium iodide). RA: Retinoic acid, Shh: Sonic hedgehog, LIF:
Leukemia inhibitory factor, BDNF: brain derived neurotrophic factor, GDNF: Glial derived neurotrophic factor, AA: Ascorbic acid, NI: Neural induction,
NE: Neural ectoderm, NT: Neural-like tube, DN: Differentiated neural cells.
doi:10.1371/journal.pone.0022856.g001
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the hESC and NI stages and between the NI and MN stages (rNI/
MN=0.68, rhESC/MN=0.7) (Figure S1).
The 5955 differentially expressed transcripts were categorized
into five expression groups (Fig. 5), including (A) 2589 transcripts
that were up-regulated in DNs compared to other stages, (B) 747
transcripts that were up-regulated in NEs, (C) 346 transcripts that
were up-regulated in hESCs and NIs compared with NEs and
DNs (D) 95 transcripts that were up-regulated in NIs compared to
other stages, and (E) 2520 transcripts that were down-regulated in
differentiated neurons (Table S2).
We performed a GO analysis of differentially expressed genes in
different clusters using BINGO (v. 2.3) software; the hypergeo-
metric test and the Benjamini and Hochberg false discovery rate
(FDR) were used for statistical tests and multiple testing
corrections, respectively. According to the expression patterns in
the preliminary results, transcripts were categorized in two main
clusters, first cluster contains transcripts that were up regulated in
neural differentiation and second cluster contains undifferentiated
associated transcripts, transcripts involved in neurogenesis,
axonogenesis and gliogenesis were over represented in first class
while cell cycle, DNA replication and repair, Mitosis and cell
proliferation processes were over represented in undifferentiated
cluster (Table S3).
Genes that were up-regulated in DNs (cluster A, Fig. 5, 6A)
were mainly involved in neurogenesis, axogenesis, neuron
migration, axon guidance, neurotransmitter secretion and synaptic
transmission. These include the up-regulation of various genes
related to differentiated neurons and glia, such as MAPT
(microtubule associated protein tau) and other tubulin associated
genes, synapse formation (SNAP25, SNAPB), septins, stathmins,
intermediate filaments and axon guidance (ROBO-SLIT) mole-
cules (Table S2). We also observed up-regulation of axon guidance
cues and neurotrophins, including ROBO2 and ROBO3 and their
receptors SLIT2 and SLIT3, Eph receptors (EFNB3, EPHA3,
EPHA5, EPHA8, EPHB1, EPHB3) and their ligands, and
semaphorin receptors (SEMA3E, SEMA4F, SEMA5B, SEMA6C)
(Table S2).
The protachykinin gene (TAC1), tyrosine hydroxylase (TH) and
the somatostatin gene (SST) were also among the highly expressed
transcripts in differentiated neural cells. As the expression data
show, peptide-releasing neurons (tachykinin, somatostatin, neuro-
tensin peptides) coexist in culture with dopaminergic (DA) and
gamma aminobutyric acid producing (GABAnergic)neurons,
although their development may be different but this coexistence
might be the result of neurotransmitter colocalization. There are
many reports of colocalization of neurotransmitters in one neuron,
especially neuropeptides, neurotensin and dopamine (DA) in
dopaminergic neurons and also for somatostatin and GABA in
GABAergic neurons [19,20,21].
The genes that were up-regulated in NEs (cluster B) were
mainly involved in appendage development, epithelium develop-
Figure 2. Inward currents recording in the differentiated neurons on two and four weeks after plating at DN stage. The
electrophysiological protocol used for eliciting currents was as follows: voltage steps (25 ms duration) from a holding potential of -70 mV to a range
of test potentials between -90 and +100 mV (10 mV increments) (A). Representative current tracing recorded from differentiated neurons before and
after blocked by Nifidipine demonstrating the presence of Ca
++ currents in these cells (B and C). I-V relationships for inward currents are shown (D).
Action potential- like recordings in the differentiated neurons (E). b: P,0.01, c: P,0.001.
doi:10.1371/journal.pone.0022856.g002
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PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e22856Figure 3. Confirmation of array data with quantitative real time RT-PCR for transcripts that were changed during differentiation.
Real time PCR data (A) for stem cells specific transcripts (POU5F1, SOX2, ALPL and NANOG) that were down regulated during neural differentiation
compared with array data (B). The expression of neural progenitor specific transcripts (FOXA2, Nestin and PAX6) and maturation markers (TH, HOXB5,
HOXA5 and HOXA2) also compared. In all of the above transcripts, real time RT-PCR data confirmed the array results, just in the case of ACTB gene,
that has a background expression in differentiated neurons in the array data, the real time data revealed that ACTB was down regulated in the neural
differentiation. SOX1 expression also was not significantly changed in array (data was not shown) but has a background expression in differentiated
neurons in the real time PCR data. Expression data were analyzed with the DDCT method.
doi:10.1371/journal.pone.0022856.g003
Figure 4. The diagram represents up- and down-regulated genes at different stages compared with hESCs. Significantly expressed
transcripts (P,0.05, FC$1.5) used as an input transcripts for clustering. The number of differentially expressed genes increased as differentiation
progressed.
doi:10.1371/journal.pone.0022856.g004
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22856Figure 5. Hierarchical clustering of 5955 differentially expressed genes was performed using the mean signal intensity for each
replicate. Three biological replicates of hESCs and differentiated cells at the NI, NE, and DN stages were compared and showed show high intraclass
correlations compared with interclass correlations. Five distinct clusters were distinguishable based on the expression patterns of the different cell
types. The differentially expressed transcripts were clustered into five expression groups, including (A) 2576 genes that were upregulated in DNs
compared to other stages; (B) 720 genes that were upregulated in NEs; (C) 326 genes that were upregulated in hESCs and NIs compared with NEs and
Gene Expression Analysis of hESC Differentiation
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Differentially expressed genes in this group may be involved in
basic molecular changes that underlie the conversion of progenitor
cells to neural cells, including cell fate decisions and triggers for
differentiation.
The expression of several progenitor marker genes, including
LMX1a, MSX1, ALDH1A1 (dopaminergic progenitors), SOX10
(oligodendroglial precursors) and PCP4 (Purkinje neuron protein),
as well as genes involved in tight junctions among epithelial cells
(AMOT), and proliferation of neural progenitors, such as WNT1
and WNT3a, were higher in NEs. Transcripts of genes involved in
neural tube development and patterning, such as ALDH1A2,
FOXA2, VANGL2, ZNF358, are also among the genes that were
up-regulated in NEs (Fig. 6B).
Several genes that were overrepresented in both hESCs and NIs
were grouped together in cluster C (Fig. 5). These include genes
involved in the negative regulation of cell migration and
endothelial proliferation, the regulation of cell adhesion, histone
methylation in the H3K9 position and the regulation of FGF and
BMP signaling (Fig. 6C). Also represented in this group were genes
for several adhesion molecules, including COL1A1 and COL6A3,
neuroplastin, neuroligin and thrombospondins. These genes are
involved in cell-ECM interactions, cell migration and axon
guidance, which are crucial for hESC derived neural cells
maintenance. The expression pattern of these genes revealed that
the extracellular environment of hESCs might be more intimately
related to the developmental lineage than to the biological
properties of the neural plate. Neuroplastin (NPTN) is a
glycoprotein that belongs to the immunoglobulin superfamily of
cell adhesion molecules (CAMs). This gene is also involved in the
long-term potentiation of hippocampal excitatory synapses
through the activation of p38MAPK [22]. Recently, it was
demonstrated that neuroplastin binds to and activates fibroblast
growth factor receptor 1 (FGFR1) [23], and it may have a function
in FGF signaling in hESCs. Neuroligin (NLGN4X) is a putative
neuronal cell surface protein involved in cell-cell-interactions and
may be involved in the formation and remodeling of central
nervous system synapses [24]. It may also play a role in cell-cell
interactions in hESC colonies. Thrombospondin family members
(THBS4 and THBS2), which are down-regulated at the NE and
DN stages, are adhesive glycoproteins that are involved in cell-cell
and cell-ECM interactions [25]. THBS4 forms a pentamer and
can bind to heparin and calcium, suggesting that this protein
might be involved in local signaling in the developing and adult
nervous system; its effect on the proliferation of endothelial cells is
clear [25]. Another enriched protein in cluster C was JARD2,
which modulates histone methyltransferase activity and promotes
the recruitment of histone methyltransferase complexes [26] to
their target genes. It also has a function in the neural tube fusion
process [27]. The JARD2 protein binds DNA and mediates the
recruitment of the PRC2 complex to target genes in ESCs. In
ESCs, JARD2 associates with the PRC2 complex and inhibits
trimethylation of Lys-27 of histone H3 (H3K27me3) by the PRC2
complex, playing a key role in the differentiation of ESCs and
normal embryonic development [26].
Genes that are up-regulated in NIs (cluster D) were enriched in
organogenesis, cell fate commitment, cell-cell signaling and
developmental induction (Fig. 5, 6D). These include several well-
Figure 6. Expression patterns of representative genes from different expression clusters were presented in Figure 3. (A) transcripts
that are highly up-regulated in DNs compared with the other stages; (B) transcripts that are enriched in NEs; (C) transcripts that are mainly up-
regulated in hESCs and NIs; (D) genes that are enriched in NIs; and (E) highly abundant genes in hESCs.
doi:10.1371/journal.pone.0022856.g006
DNs; (D) 98 genes that were upregulated in Nis compared to the other stages; and (E) 2234 genes that were mainly down-regulated in differentiated
neurons (Table S2).
doi:10.1371/journal.pone.0022856.g005
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POU3F1, NPAS1, CYP26A1 and FGF8 (Fig. 6D). The higher
expression levels of genes that modulate post mitotic neuron
maintenance, such as FBXO2, may be required for the
regionalization of neurons [28]. Several genes that were up
regulated in NI are among a set of genes that are already known to
be highly expressed in the developing CNS, including the Six6
gene, which is expressed abundantly in the brain, cerebellum and
specific precursors of neural retina cells [29], and the FGF3 gene,
which is expressed in the hindbrain and whose expression is
required for hindbrain patterning [30]. POU3F1 also known as
OCT6 is a member of the pou domain family of proteins and is
involved in neural ectoderm formation; its expression is down
regulated upon ESC differentiation and increases again during
brain development [31].
The protein encoded by the NPAS1 gene is a member of the
basic helix-loop-helix (bHLH)-PAS family of transcription factors
and is specifically expressed in neural tissue [32]. NPAS1 in mice
modulates the transcription of erythropoietin by binding to its
enhancer region in vivo; thus, it indirectly controls oxygen-
responsive elements during late embryogenesis and central
nervous system development [33]. CYP26A1 plays a key role in
retinoic acid (RA) metabolism. Many isoforms of this gene and
other subunits of the P450 cytochrome are overrepresented at the
NI stage, highlighting the importance of the retinoic acid (RA)
metabolic pathway in the neural initiation stage [34]. Another
gene, CPZ, modulates the WNT signaling pathway by cleaving
some undefined protein or by binding to the WNT molecule [35].
FGF8 is also overexpressed in NI, and its expression is
downregulated as differentiation progresses (Fig. 6). FGF8 is a
paracrine factor that appears to have a function during
dopaminergic neuron specification and proliferation [36]; it works
cooperatively with SHH in the specification of midbrain neurons.
Neural rosette cells comprise neural progenitors from the neural
crest and CNS neurons. Neural crest progenitors express
S100A11, MSX1, TFAP2A, TFAP2B and ERBB3 abundantly
in the rosette stage (Fig. 6B). During the early development of
neural cells, the MEIS1 and MEIS2 homeobox genes can
positively control PAX6 transcription and induce hESCs toward
neuralization [37]. The extrinsic factor RA may trigger neural
specific genes and induce the neural fate [38], and RA may also
affect anterior-posterior pattern formation by inhibiting BMP
signaling with Noggin, which induces the formation of neural
ectoderm. Shh protein can induce Foxa2 and ventralize neural
progenitors and, in a positive regulatory loop, FOXA2 can induce
endogenous SHH and inhibit NKX2.2 [39] and also the
serotonergic phenotype. Endogenous transcription of FGF8
resulting from RA exposure [40] can induce WNT1 expression
that cooperatively with FGF8 can induce neural progenitors to
differentiate into TH-producing cells.
A major group of differentially expressed genes includes
transcripts that were down-regulated during differentiation
(Fig. 5). This group includes genes involved in the cell cycle,
mitosis and metabolism as well as genes involved in the
development of other germ layer clusters (Fig. 6E). Several major
ESC markers, including OCT4, NANOG, PRDM14, and GAL,
were grouped in this cluster (Fig. 6E). Because OTX2, a gene
involved in forebrain-hindbrain patterning, was also down-
regulated during differentiation, the results suggest that poster-
iorized neurons were generated during differentiation in this study
[41]. Matrix associated genes, including MMP1, THBS1, and
ITGB1BP3, were also among the hESC enriched genes,
suggesting that expression of these genes provides an environment
conducive to the proliferation of stem cells. DNA methyltransfer-
ase genes and noncoding genes homologous to OCT4 control the
epigenetic state of hESCs and are important classes of genes for
stem cell maintenance. Some antagonists of FGF signaling, such as
SPRY1, were also overrepresented in hESCs. SPRY1 is involved
in cortical neuron pattern formation and inhibits caudal cell fates
[42]; its role in hESCs with a high concentration of FGF is not
clear and may be important for the fine tuning of FGF signaling in
ESCs (Fig. 6E).
Overall, our study found that the transcriptome is extremely
complex and dynamic during early neural differentiation of
hESCs. All transcripts that were modulated during differentiation
were placed in upregulated and downregulated clusters and were
analyzed using the KEGG pathway database and ClueGO
software. With a two-sided hypergeometric test, genes were
assigned to pathways. The pathway information for each cluster
was analyzed, and pathways represented in each cluster were
identified and compared. Our results showed that some transcripts
that were involved in metabolic pathways were downregulated
during differentiation. Pentose and glucuronate interconversions,
fatty acid turnover (for membrane biogenesis), DNA replication,
mismatch repair, recombination and immune response pathways
were hyper expressed in hESCs, but not in neurons (Fig. 7, Table
S4). Nucleotide metabolism and cell cycle pathway members were
also highly expressed in hESCs. Genes involved in nitrogen
metabolism, apoptosis, NOTCH signaling, axon guidance,
neurotrophin signaling, Parkinson’s disease and prion disease are
highly abundant molecular pathways that were overrepresented in
differentiated neural cells (Fig. 7, Table S4). In ESCs, mTOR
signaling can stabilize OCT4, SOX2 and NANOG expression
and can negatively control the induction of endoderm and
mesoderm from ESCs. Inhibition of mTOR with rapamycin
enhanced the expression of endoderm and mesoderm markers in
treated EB and impaired the pluripotency of hESCs, but this effect
was not observed in neural differentiation [43]. According to our
results, mTOR signaling functions in neural induction. Transcripts
associated with mTOR (S6K1) were upregulated during neuro-
genesis (Table S4). NOTCH signaling is also active in hESC-
derived neural progenitors and has an important function in the
proliferation and differentiation of NPCs. Inhibition of NOTCH
can disrupt the maintenance of stem cell characteristics of NPCs
[44]; [45], by suppressing the HES1 and HES5 genes, which
negatively control the expression of the proneural genes MASH1
and NGN1 [46,47,48]. The NOTCH signaling members
NOTCH1, DTX1, DTX3, DLL1, DLL3, HES5 and JAG2 were
expressed more strongly at the NE stage compared to hESCs, and
this stronger expression continued as the cells differentiated into
final differentiated neurons. As shown previously, NOTCH
signaling negatively controls neurogenesis in a stepwise process;
in the first step, its activation leads to gliogenesis as opposed to
neurogenesis, and in the second step, its activation promotes the
production of astrocytes and inhibits the production of oligoden-
drocytes and neural fates [48].
Another pathway that confers one of the characteristics of NPs
is the Toll like receptor (TLR) pathway. The TLR pathway is
involved in the development of CNS and the innate immune
system and functions in cell proliferation and NPC differentiation
[49,50]. The TLR pathway has an immunomodulatory effect on
NPCs via the activation of TNF-alpha [51]. It seems that members
of the TLR pathway (AKT1, CD14, FOS, IFNAR1, IL8, JUN,
MAPK10, MAPK11, MAPK3, PIK3R1, PIK3R2, RELA, SPP1)
are more highly expressed in NEs and DNs (Table S4). WNT
signaling, MAPK signaling, Jak-STAT signaling, Hedgehog
signaling, and TGF-beta signaling are active pathways in NEs
and DNs, but these pathways do not share common proteins. The
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although the expression of WNT4, WNT7A, WNT7B and
FZD9 increased with neural differentiation (Table S4). Neural
progenitors (NPs) have some overlap with ESCs in the expression
patterns of WNT pathway molecules. The DKK1 gene, an
inhibitor of WNT signaling, was suppressed during neurogenesis.
However, another inhibitor, DKK3, had an increased expression
level, which may explain how different members of the WNT gene
family may control differentiation of different cell types.
Metabolism associated genes are found in both ESCs and
differentiated cells. Genes involved in the pentose phosphate
pathway, galactose metabolism, ascorbate and aldarate metabo-
lism and fatty acid elongation and metabolism have increased
expression levels in stem cells. The beta-1,4-galactosyltransferase
(B4GALT1) protein is an enzyme that participates in glycocon-
jugation, lactose biosynthesis, and galactose metabolism in liver
cells. This enzyme is targeted to the plasma membrane of
intestinal cells and absorbs galactose from the lumen; it may also
function in adhesion [52]. Previous studies have shown that the
B4GALT1 promoter has a binding site for E1AF, and induction
of B4GALT1 expression by E1AF can lead to lung cancer [53].
Genes in the glycosphingolipid biosynthetic pathway are
overrepresented in neural cells compared with ESCs. Glyco-
sphingolipids (GSLs) are a group of bioactive glycolipids that
includes cerebrosides, globosides, and gangliosides and are
involved in cell adhesion, modulation of growth factor/hormone
receptors, antigen recognition, and protein trafficking. GSLs are
more active in neural tissues compared to hESCs, and their
dysfunction may lead to the accumulation of GSLs and lysosomal
storage diseases (LSDs) [54]. NOTCH signaling in neural system
development has multiple functions. Not only can NOTCH
switch a neural cell fate decision [55], but NOTCH signaling also
plays an important role in the maintenance of neural stem cells
[56]. NOTCH molecules are also needed for cell fate
determination in hESCs as they differentiate into the three germ
layers [57]. In this study expressed transcripts in this pathway
were delta-like ligands (DLL1, DLL3), jagged (JAG2) and the
receptor, NOTCH1. Activation of NOTCH1 can activate the
transcription of HES5 and determine neural fate.
Regulatory network of NPs at the NE stage
We established an interaction network of modulated genes at
the NE stage using the STRING database. The full regulatory
interaction network was composed of 96 nodes that were up- or
down regulated more than 1.5-fold in rosette cells compared with
hESCs. The data are presented in Figure S3. We then constructed
a subnetwork of 44 nodes of NE-enriched genes (Fig. 8). Our
results highlight the role of the TGFß family in the proliferation of
neural progenitors. Genes in the TGFß superfamily are major
players in the differentiation and maintenance of NPs. ID1 is a key
gene in the proliferation of NPs [58] and is under the control of
LEFTY2, another helix-loop-helix transcription regulator. The
genes ID3 and ID2 are also activated by LEFTY2 and are
important for the survival, proliferation [59] and specification [60]
of neural crest progenitor cells. It seems that the LEFTY 2 gene is
involved in NP proliferation (Fig. 8). MSX1 can activate BMP4,
Figure 7. Pathway analysis of enriched transcripts in hESC (light blue) and differentiated cells (dark blue). Enriched transcripts
searched against KEGG pathway database for finding the members involved in the signaling pathways, mostly transcribed members in each stage (up
to 60%) in undifferentiated or neural differentiated cells compared and depicted in the figure. Common active pathways in both stages have not
been shown.
doi:10.1371/journal.pone.0022856.g007
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tion of ID2 and ID3. MSX1 is controlled by LMX1A and, in a
positive feedback loop, can promote WNT1 expression. Recipro-
cally, WNT1 can positively activate LMX1A expression, leading
to dopaminergic progenitor proliferation [61]. Temporal gene
expression analysis of 55 cell cycle signaling molecules with
significant modulation during differentiation revealed that CDK2,
CDK4, CDK6 and molecules involved in the G2-S phase
transition, including CDC2, CDC25C and MAD2L1, have higher
expression levels in NEs compared to hESCs. TFDP1, another
transcription factor that binds to EF1 and controls the transcrip-
tion of EF1 target genes [62], is also upregulated in NEs (Figure
S4).
In summary, transcriptional profiling during differentiation of
hESCs to neural cells reveals systematic changes in the expression
levels of transcription factors that control fate decisions, paracrine
factors that coordinate the differentiation process, cell metabolism,
cytoskeleton and genes in neurotransmitter secretion pathways.
Our results clarify the gene expression changes that occur during
differentiation of neural cells. Future studies will uncover
functional changes in different neuronal subtypes and glia.
Supporting Information
Figure S1 The expression levels of approximately 6000
transcripts are depicted in pairwise plots and correlations among
samples, calculated separately for each sample pair (A: hESC, B:
NI, C: NE, D: DN). The distance of points from the regression line
indicates the diversity of expression between two samples. The X
and Y axes represent the fold changes of transcript levels. The
number of genes up or downregulated by more than 2-fold in
compared samples is shown on the other side of the matrix.
(TIF)
Figure S2 Western blot analysis of 25 ug of total protein extracts
from Royan H6 cells. Equal amounts of protein from total cell
lysates of human ESCs and neural differentiated cells were
subjected to SDS-PAGE followed by western blotting and
visualization with an ECL detection kit. Bands were visualized
with hyperfilm ECL (GE Healthcare, USA) and scanned with a
GS800 densitometer (Bio-Rad, USA). ESCs, neural rosette and
differentiated neural samples (three replicates) were analyzed with
antibodies against Nestin and tyrosine hydroxylase (TH) proteins.
In panel B, western blot and qRT-PCR results for Nestin and TH
were quantified to compare the mRNA and protein levels at the
NE and DN stages.
(TIF)
Figure S3 A regulatory network of 96 nodes, modulated by a
1.5-fold or greater up or downregulation in rosette cells compared to
hESCs. The downregulated nodes are shown in green, and the
upregulated nodes are shown with red circles. Green arrows indicate
an activation mode, red arrows indicate an inhibitory mode, purple
edges indicate an expression mode, and blue edges represent post-
translational modification of source genes or target genes.
(TIF)
Figure S4 Cyclin dependent kinase and other transcripts
associated with cell cycle progression and control, according to
BINGO results, were clustered with Expander. The resulting
image shows that the genes involved in cell cycle control are
differentially expressed in embryonic stem cells and the neural
progenitor state. Some of the transcripts are overexpressed in
differentiated neurons and inhibit transition from the G1 phase
(e.g., CDKN1B, CDKN2D).
(TIF)
Table S1 List of primers used for Real-Time PCR analysis.
(DOC)
Figure 8. The gene regulatory network of 44 upregulated transcripts in neural rosette cells compared to hESCs. The STRING database
was used to construct a regulatory network of differentially expressed transcripts. Then, a regulatory sub-graph was extracted from this network by
selecting edges with inhibitory or activatory regulatory interactions. The visulation of networks was performed using Cytoscape. Green arrows
indicate an activation mode, red arrows indicate an inhibitory mode, purple edges indicate an expression mode, and blue edges represent post-
translational modification of source genes or target genes.
doi:10.1371/journal.pone.0022856.g008
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modulated during differentiation in at least one stage compared
with hESCs
(XLSX)
Table S3 BiNGO analysis of differentially expressed transcripts
in neural differentiation. Over represented biological processes
across transcripts which differentially expressed calculated com-
pared to all annotation from human database
(XLSX)
Table S4 Pathway analysis of differentially expressed transcripts.
Up-regulated transcripts in cluster 1 compared to down regulated
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